PGEN
Precigen Inc
$8.07
0.30 (3.87%) Today
0.02 (0.25%) After-hours
— up— down
Market Cap
$2.88B+121.8%
Revenue (TTM)
$73.87M+1875.0%
Net Income (TTM)
$-184,173,066
$-184,173,066EPS (TTM)
-0.52
-0.52Shares Out
356.51M
356.51MForward P/E
14.31
14.31Open
$8.05
$8.05Previous Close
$7.75
$7.75Day Range
$7.80 – $8.10
$7.80 – $8.1052-Week Range
$2.99 – $8.27
$2.99 – $8.27Beta
1.04
1.04Earnings Date
Nov 11, 2026
Nov 11, 2026Volume
4.14M
4.14MAvg Volume
5.09M
5.09MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout PGEN
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Related
News
N/AN/AN/AN/AN/A
Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs?
Yahoo · 22h ago
Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap?
Yahoo · 3d ago
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?
Yahoo · 4d ago
Precigen (PGEN) Secures FDA Platform Status For AdenoVerse And Future Therapies
Yahoo · 4d ago
B. Riley Securities Initiates Coverage On Precigen with Buy Rating, Announces Price Target of $12
Benzinga · 4d ago